Metropolitan Life Insurance Company (MetLife)’s VistaGen Therapeutics VTGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-506	Closed	-$13.4K	–	2360
2022 Q2	$13.4K	Hold	506	–	–	﹤0.01%	2233
2022 Q1	$18.8K	Sell	506 -1,640	-76%	-$61.1K	﹤0.01%	2125
2021 Q4	$126K	Hold	2,146	–	–	﹤0.01%	2342
2021 Q3	$176K	Hold	2,146	–	–	﹤0.01%	2173
2021 Q2	$203K	Buy	+2,146	New	+$203K	﹤0.01%	2127